Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).
about
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusionP-glycoprotein mediated drug interactions in animals and humans with cancerPharmacokinetic interactions of herbs with cytochrome p450 and p-glycoproteinThe Alterations in the Expression and Function of P-Glycoprotein in Vitamin A-Deficient Rats as well as the Effect of Drug Disposition in VivoClinically relevant safety issues associated with St. John's wort product labels.Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.Biphasic regulation of P-glycoprotein function and expression by NO donors in Caco-2 cells.Establishment of a human hepatoma multidrug resistant cell line in vitroABCB1 genetic variants in leukemias: current insights into treatment outcomesOral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review.Drug-drug interaction studies of cardiovascular drugs involving P-glycoprotein, an efflux transporter, on the pharmacokinetics of edoxaban, an oral factor Xa inhibitor.Sucralose, a synthetic organochlorine sweetener: overview of biological issuesSweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with "ersatzdroges".MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results.Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challengesExposure of LS-180 cells to drugs of diverse physicochemical and therapeutic properties up-regulates P-glycoprotein expression and activity.Induction of expression and functional activity of P-glycoprotein efflux transporter by bioactive plant natural products.Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.An overview of the evidence and mechanisms of herb-drug interactions.The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRPInterindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjectsDetermination of Vitamin D Serum Levels and Status of the C3435T Polymorphism of Multidrug Resistance 1 Gene in Southeastern Iranian Patients with Ulcerative Colitis.Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.Complementary and alternative medicine in present day oncology care: promises and pitfalls.New oral anticoagulants and the cancer patient.Unproven Therapies for Diabetes and Their Implications.Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases.Tissue-specific alterations in expression and function of P-glycoprotein in streptozotocin-induced diabetic rats.Practical application of toxicogenomics for profiling toxicant-induced biological perturbations.Drug interactions and the pharmacist: focus on everolimus.Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation.Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions.Interactions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management.Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban.Drug interactions with new oral anticoagulants in elderly patients.Pharmacokinetic herb-drug interactions with traditional Chinese medicine: progress, causes of conflicting results and suggestions for future research.
P2860
Q24273350-8EDBA5FB-6002-4250-A00C-90EF5D8914DCQ28085291-FB2BEE87-7253-4520-8DEA-7E0B27F19F51Q28087178-536ECDAB-10ED-4405-AB38-15FDBDE7ABD7Q28571953-397A4459-CF71-4F86-B6A8-CE36497CA0F3Q33352845-08DCC0E4-490D-4B29-8E87-8F02A350D418Q33509452-DD8BE9A2-37AE-447B-AED8-4259183F7E0BQ33567500-1C9FD40C-B89F-4407-B925-AD072C6DCFCFQ33574625-404C7167-1587-4864-85B5-2D879000DEA6Q33707782-3AA202D5-B4DB-43F0-8A26-18A181887A43Q34252907-687585CF-370F-4D82-8121-7F3064987E60Q34306204-0DA2A566-53A5-46FC-B9F9-611BA6271B77Q34653407-73A67056-316E-4919-9007-297F8C740A1EQ34657381-B07244AB-DB34-4E92-80F4-5045F9EF9309Q34674058-0E55CFC9-16CD-4B45-BFBD-BCD6758ACEE0Q34959857-9D4D57F3-CAE0-428D-8DC7-69A9BBEF3DB1Q34994901-A3FE503C-D99C-413B-BA9C-29BFA4060BA8Q35164876-8A51F099-869D-4FC0-8A88-EB454DFE039DQ35212135-E5D9DA16-4834-4C14-854F-E675F7010757Q35301130-619CFF01-590D-4254-9A36-D51D224F083EQ35915497-75F53FFB-549C-4D7B-866E-A1EFB7E37325Q35919968-3BD5EACE-9229-450B-A62B-5D272C9565C1Q36086400-4DEC2A41-5C8A-4C34-8C24-63A971DE518DQ36243658-3AD6707C-2FE0-4B6E-B35E-F7EFE62471ABQ36306906-BA855B24-E60C-4CCB-9ECD-31678098065EQ36691249-6DBCA5AA-D5B4-444C-A52B-048D2A3CB4E3Q37080236-911D98D2-2B1B-43C4-8F99-E7A2591DF67BQ37235819-15D4B404-0C42-4488-AB7A-EAE7C0168FAEQ37519054-DC8E7373-A792-41CE-B708-798A40758DF8Q37562491-324EE25B-C8C4-4501-B29C-2E7B0C548565Q37636632-FD2425C8-6DCB-4FA5-988E-1A99FBEA082BQ37640084-326A8331-D82F-43D1-8648-4193B9DA993CQ37729499-CB8F3AD2-0E32-4CAD-B041-AADDB70ADEE9Q37801286-ACACE516-5DEE-4042-8957-6F1E86801A7AQ38113771-05DA6320-7C41-4243-B54E-D56677DED063Q38156338-2E0D3D02-B155-46A1-82D0-B45384AE972DQ38202698-59473302-385A-40D0-A8DF-B633E4B337E0Q38283110-B6F01577-3078-4A76-933C-150E3AB7CE59Q38330349-1FF7719E-63E4-4A66-94C0-6D2351879477Q38616215-B490CC88-0A57-4192-A395-59EB98613AFAQ38750365-B99B44D0-93EF-459F-84CA-E5DF2B7B75EA
P2860
Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Concise review: Clinical relev ...... ABCB1 (MDR1, P-glycoprotein).
@en
type
label
Concise review: Clinical relev ...... ABCB1 (MDR1, P-glycoprotein).
@en
prefLabel
Concise review: Clinical relev ...... ABCB1 (MDR1, P-glycoprotein).
@en
P2093
P1433
P1476
Concise review: Clinical relev ...... ABCB1 (MDR1, P-glycoprotein).
@en
P2093
Jan H M Schellens
Jos H Beijnen
Roberto Mazzanti
Serena Marchetti
P304
P356
10.1634/THEONCOLOGIST.12-8-927
P577
2007-08-01T00:00:00Z